| Ytd | 32.83% | |
| 1y | 96.61% |
| Open | 40.92 | Prev Close | 40.91 | Low | 39.70 | High | 41.00 | Mkt Cap | 2.59B |
| Vol | 37.74K | Avg Vol | 414.61K | EPS | 1.14 | P/E | 35.89 | Forward P/E | 32.89 |
| Beta | 0.05 | Short Ratio | 6.49 | Inst. Own | 59.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 39.79 | 200-d Avg | 33.75 | 1yr Est | 47.00 |
GRDN News
Bessemer Group Inc. purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE: GRDN) during th
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation’s largest and most innovative long-t
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concep
Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The lat
Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy a
Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future?
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 202
Guardian Pharmacy Services NYSE: GRDN reported what executives described as a solid first quarter of
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Z
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billio
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earni
Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrade
B of A Securities analyst Allen Lutz initiates coverage on Guardian Pharmacy Service (NYSE:GRDN)
Shares of Guardian Pharmacy Services, Inc. (NYSE: GRDN - Get Free Report) have been given an average
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) will be attending the Bank o
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
GRDN and ESCA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 10th, 2026.
ESCA, GRDN, TPST, ASTE and ECG have been added to the Zacks Rank #1 (Strong Buy) List on April 10th,
Guardian Pharmacy Services (GRDN) shares have started gaining and might continue moving higher in th
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The lat
Jefferies analyst Brian Tanquilut initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) wit
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were update
Stock futures slightly lower, Alibaba falls after downbeat earnings, other stocks decline in pre-mar
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of its
Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4
US stock futures mixed on Thursday, with focus on Accenture, Micron, Alibaba's earnings. Guardia
The Offering for GRDN's Class A common stock, consisting of 3,980,000 shares being offered by ce
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billio
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.33 per share which beat the
Stephens & Co. analyst Scott Fidel maintains Guardian Pharmacy Service (NYSE:GRDN) with a Ov
Guardian Pharmacy Services (NYSE:GRDN), one of the nation's leading long-term care ("LTC"
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
FY 2025 Outlook – Raising GuidanceThe updated guidance below excludes future acquisitions. Updated G
